Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Abstract Background The use of treatment planning prostate MRI for Stereotactic Body Radiation Therapy (SBRT) is largely a standard, yet not all patients can receive MRI for a variety of clinical reasons. Thus, we aim to investigate the safety of patients who received CT alone based SBRT planning fo...
Main Authors: | Katherine Amarell, Anna Jaysing, Christopher Mendez, Jonathan A. Haas, Seth R. Blacksburg, Aaron E. Katz, Astrid Sanchez, Angela Tong, Todd Carpenter, Matthew Witten, Sean P. Collins, Jonathan W. Lischalk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-022-02026-1 |
Similar Items
-
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease
by: Jonathan W. Lischalk, et al.
Published: (2021-07-01) -
Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01) -
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation
by: Jonathan W. Lischalk, et al.
Published: (2024-02-01) -
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
by: Justin Leu, et al.
Published: (2023-03-01) -
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
by: Justin Leu, et al.
Published: (2023-04-01)